Stockreport

Novocure Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update

NovoCure Limited - Ordinary Shares  (NVCR) 
Last novocure limited - ordinary shares earnings: 4/30 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: novocure.com/investor-relations
PDF Full year 2024 net revenues of $605 million and fourth quarter net revenues of $161 millionOptune Lua® received FDA approval for the treatment of metastatic non-small ce [Read more]